Proactive Investors - Run By Investors For Investors

Tidal Royalty in strategic financing partnership with Harborside parent FLRish

In exchange for royalties on sales, Tidal Royalty will provide US$10 million in financing to prospective dispensary operators licensing the “Harborside brand”
cannabis investment
Harborside's flagship store in Oakland, California, is the largest medical cannabis dispensary in the US

Tidal Royalty Corp (CSE:RLTY, OTC:TDRYF), the cannabis industry financier, has entered into a financing partnership with FLRish (“Harborside”), the parent company of the Harborside dispensaries in California.

Under the deal’s terms, in exchange for royalties on sales, Tidal Royalty will provide US$10 million in financing to prospective dispensary operators licensing the Harborside brand. Each potential financing transaction for dispensaries will be evaluated on a case-by-case basis and specific financing terms will be negotiated between the companies.

“Harborside is one of the preeminent cannabis companies in the US,” said Paul Rosen, Tidal Royalty’s CEO. “Through our strategic financing partnership, Tidal Royalty would provide select operators with the capital required to launch a dispensary licensing the “Harborside” brand in exchange for a royalty on sales.”

Founded in 2006 by cannabis industry activist and entrepreneur Steve DeAngelo, Harborside is a California-licensed cannabis operator, which runs two dispensaries and one of California’s largest cultivation facilities. Its flagship location in Oakland, California is the largest medical cannabis dispensary in the US.

READ: Tidal Royalty makes strategic investment in Lighthouse Strategies, maker of the first non-alcoholic cannabis-infused craft beer

The transaction increases Tidal Royalty’s portfolio of investments in licensed cannabis operators and follows the company’s announcement of its financing of Lighthouse Strategies, which has developed the world’s first non-alcoholic cannabis-infused craft beer and liquor brand.

Tidal Royalty is currently knee-deep in the process of evaluating other investment opportunities across the US, including in California, New York, Illinois, Ohio, Pennsylvania, Texas and Michigan.

As part of the Harborside deal, Tidal Royalty has also purchased C$3 million of senior unsecured convertible debt units, which pay 12% interest and are convertible into Harborside common shares. The units also include warrants to purchase 87 additional common shares per unit, for 24 months after the closing date of the financing.

Tidal Royalty provides royalty financing to the U.S. regulated cannabis industry.

Shares traded 3% higher to hit C$0.17 on Wednesday. 

Contact Ellen Kelleher at [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full RLTY.U profile View Profile

Tidal Royalty Corp. Timeline

Related Articles

FSD Pharma facility
June 11 2019
The indoor hydroponic facility will be optimized for large-scale, medical-grade cannabis production and once complete, is expected to have over 3.9 million sq/ft available for production
medical cannabis concept
February 10 2019
AusCann is a fully integrated early-mover pharmaceutical cannabinoid company.
cannabis extract
January 16 2019
The Kelowna, BC-based cannabis company specializes in the research, development, production, and testing of high-quality cannabis extracts and oils
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use